NAUSP, which is administered by SA Health, is a key AURA Surveillance System partner and provides an important tool for hospitals to support their local antimicrobial stewardship programs. It also contributes to meeting the requirements for accreditation against the National Safety and Quality Health Service (NSQHS) Standard Preventing and Controlling Healthcare-Associated Infection. NAUSP is a voluntary program that focuses on standardised measurement of antimicrobial use in Australian adult public and private hospitals. In excess of 200 hospitals from all states and territories currently contribute to NAUSP; including all principal referral hospitals.

Antimicrobial usage for adult hospitals usage is measured in defined daily doses per 1,000 occupied bed days. The Commission has published a series of annual reports on analyses of NAUSP data, the most recent of which relates to 2016. NAUSP publishes six monthly benchmarking reports for hospital peer groups, speciality units, states and territories.

The 2016 NAUSP annual report included analyses of data contributed by 169 hospitals (143 public and 26 private) in 2016. All Principal Referral Hospitals and 88% (93/106) of Public Acute Group A and B hospitals participated in the program in 2016.

The analyses showed a continuing decline in aggregate total-hospital antibacterial usage since 2012, likely reflecting the effectiveness of antimicrobial stewardship programs associated with implementation of the National Safety and Quality Health Service (NSQHS) Standards. Data on antifungal usage in Australian hospitals were included in the report for the first time in 2016.

For more information about NAUSP, including becoming a contributor, visit the NAUSP website.


NAUSP Publications

Antimicrobial use in Australian hospitals: Results of the 2016 National Antimicrobial Utilisation Surveillance Program

Antimicrobial use in Australian hospitals: Results of the 2015 National Antimicrobial Utilisation Surveillance Program

Antimicrobial use in Australian hospitals: Results of the 2014 National Antimicrobial Utilisation Surveillance Program